Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Income from Continuing Operations (2018 - 2025)

Arcturus Therapeutics Holdings' Income from Continuing Operations history spans 8 years, with the latest figure at 29079000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 3.09% year-over-year to 29079000.0; the TTM value through Dec 2025 reached 65783000.0, up 18.74%, while the annual FY2025 figure was 65783000.0, 18.73% up from the prior year.
  • Income from Continuing Operations reached 29079000.0 in Q4 2025 per ARCT's latest filing, down from 13448000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 118642000.0 in Q4 2022 to a low of 57666000.0 in Q1 2021.
  • Average Income from Continuing Operations over 5 years is 18438350.0, with a median of 24190000.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: crashed 509.45% in 2021, then skyrocketed 415.16% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 37645000.0 in 2021, then surged by 415.16% to 118642000.0 in 2022, then plummeted by 109.84% to 11680000.0 in 2023, then crashed by 156.89% to 30005000.0 in 2024, then increased by 3.09% to 29079000.0 in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Income from Continuing Operations are 29079000.0 (Q4 2025), 13448000.0 (Q3 2025), and 9180000.0 (Q2 2025).